Evidence map›Paper›PMID 32963227›Full record

ArticleNature communications2020

IL-33-ST2 axis regulates myeloid cell differentiation and activation enabling effective club cell regeneration.

Rania Dagher, Alan M Copenhaver, Valerie Besnard, Aaron Berlin, Fatima Hamidi, Marielle Maret, Jingya Wang, Xiaotao Qu, Yashaswi Shrestha, Jincheng Wu and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 79 citations in OpenAlex.

  1. Trial
  2. The role of myeloid immune cells in lung epithelial repair.American journal of physiology. Lung cellular and molecular physiology · 2026
    Review
  3. Review
  4. Article
  5. Targeting IL-33 in Precision Neuroimmunology: Cellular Mechanisms and Therapeutic Strategies for CNS Disorders.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. ST2 Signaling Regulates Innate Immune Responses in Kidney Injury.bioRxiv : the preprint server for biology · 2026
    Article
  15. Review
  16. Article
  17. Article
  18. Targeting alarmins in asthma: From bench to clinic.The Journal of allergy and clinical immunology · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 3 countries.

Rania DagherInserm UMR1152-Physiopathologie et Epidémiologie des Maladies Respiratoires, Université Paris, Paris, France.
Alan M CopenhaverBioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.ORCID http://orcid.org/0000-0001-5952-0455
Valerie BesnardInserm UMR1152-Physiopathologie et Epidémiologie des Maladies Respiratoires, Université Paris, Paris, France.
Aaron BerlinBioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.ORCID http://orcid.org/0000-0002-4499-8074
Fatima HamidiInserm UMR1152-Physiopathologie et Epidémiologie des Maladies Respiratoires, Université Paris, Paris, France.
Marielle MaretInserm UMR1152-Physiopathologie et Epidémiologie des Maladies Respiratoires, Université Paris, Paris, France.
Jingya WangTranslational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Xiaotao QuData Sciences and AI, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Yashaswi ShresthaTranslational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.ORCID http://orcid.org/0000-0002-5567-0277
Jincheng WuData Sciences and AI, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Gregory GautierFaculté de Médecine, Université Paris, Paris, France.
Rajiv RajaTranslational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.ORCID http://orcid.org/0000-0002-4663-0951
Michel AubierInserm UMR1152-Physiopathologie et Epidémiologie des Maladies Respiratoires, Université Paris, Paris, France.
Roland KolbeckBioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Alison A Humbles *Bioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA. alisonhumbles@gmail.com.ORCID http://orcid.org/0000-0003-0045-9340
Marina Pretolani *Inserm UMR1152-Physiopathologie et Epidémiologie des Maladies Respiratoires, Université Paris, Paris, France. marina.pretolani@inserm.fr.
AstraZeneca (United States) · USInserm · FRAstraZeneca (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence points to an indispensable function of macrophages in tissue regeneration, yet the underlying molecular mechanisms remain elusive. Here we demonstrate a protective function for the IL-33-ST2 axis in bronchial epithelial repair, and implicate ST2 in myeloid cell differentiation. ST2 deficiency in mice leads to reduced lung myeloid cell infiltration, abnormal alternatively activated macrophage (AAM) function, and impaired epithelial repair post naphthalene-induced injury. Reconstitution of wild type (WT) AAMs to ST2-deficient mice completely restores bronchial re-epithelialization. Central to this mechanism is the direct effect of IL-33-ST2 signaling on monocyte/macrophage differentiation, self-renewal and repairing ability, as evidenced by the downregulation of key pathways regulating myeloid cell cycle, maturation and regenerative function of the epithelial niche in ST2

Indexed as

AnimalsBronchiolesCell DifferentiationCytokinesDisease Models, AnimalEpithelial CellsFemaleInterleukin-1 Receptor-Like 1 ProteinInterleukin-33LungLymphocyte ActivationLymphocytesMacrophagesMiceMice, Inbred C57BLMice, KnockoutCytokinesIl1rl1 protein, mouseIl33 protein, mouseInterleukin-1 Receptor-Like 1 ProteinInterleukin-33

Identifiers

PMID32963227
PMCPMC7508874
OpenAlexW3088610553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.